4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000178
EVP, Chief Scientific Officer sold 10,000 shares at $43.98 ($439,776)
- EVP, Chief Scientific Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $32.60 | $326,000 | 103,466 | D |
| 2025-08-18 | Sale : show line 2 in the form 10b5-1 | −10,000 | $43.98 | $439,776 | 93,466 | D |
| Open-market sales · 10,000 sh · avg $43.98 · $439,776 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-18 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −10,000 | 18,869 | D |
Loading xslF345X05/edgardoc.xml…